Spectrum Pharmaceutical (SPPI) announced today that it was issued a patent for blinostat, selling under the brand name Beleodaq. The patent extension approval of Spectrum oncology drug is big news for shareholders

Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm. Co.

Our weekly best and worst reports show you stocks with the best potential returns over the coming 6 to 12 months.

Our weekly best and worst reports show you stocks with the best potential returns over the coming 6 to 12 months. Those stocks appearing in our best list should be bought while those appearing in our worst list should be sold.